Capital Research Global InvestorsCapital Research Global Investors

Institutional investor · Portfolio as of Q2 2023

Top Holdings414 positions

Checking export access…
Activity:

Microsoft Corp.

73.4M$25B6.7%$102.28+224.64%
19 qtrssince 2018-Q4
Decreased
0

Broadcom Inc

19.2M$16.7B4.5%$23.94+248.88%
19 qtrssince 2018-Q4
Decreased
0

Amazon.com, Inc.

98.1M$12.8B3.4%$104.30+24.99%
19 qtrssince 2018-Q4
Increased
61

GE Aerospace

92.6M$10.2B2.7%$56.17+53.22%
8 qtrssince 2021-Q3
Decreased
0

Abbott Laboratories

77.2M$8.4B2.3%$63.44+60.66%
19 qtrssince 2018-Q4
Increased
55

Netflix, Inc.

17.5M$7.7B2.1%$28.83+52.79%
19 qtrssince 2018-Q4
Decreased
0

UnitedHealth Group Inc.

14.4M$6.9B1.9%$246.38+82.49%
19 qtrssince 2018-Q4
Decreased
0

RAYTHEON TECHNOLOGIES CORP

66.5M$6.5B1.7%$65.94+38.97%
14 qtrssince 2020-Q1
Decreased
0

Meta Platforms Inc

21.8M$6.2B1.7%$144.75+96.38%
19 qtrssince 2018-Q4
Decreased
0

Alphabet Inc.

49.6M$5.9B1.6%$74.94+58.23%
19 qtrssince 2018-Q4
Increased
58

MasterCard Incorporated

14.5M$5.7B1.5%$247.52+55.86%
19 qtrssince 2018-Q4
Decreased
0

CANADIAN NAT RES LTD

92.2M$5.2B1.4%$10.61+134.29%
19 qtrssince 2018-Q4
Decreased
0

Philip Morris International Inc.

51.6M$5B1.3%$55.17+54.28%
19 qtrssince 2018-Q4
Increased
53

Linde PLC

12M$4.6B1.2%$339.28+8.26%
2 qtrssince 2023-Q1
Decreased
0

GILEAD SCIENCES INC

57.9M$4.5B1.2%$53.30+30.29%
19 qtrssince 2018-Q4
Decreased
0

Apple Inc.

22.8M$4.4B1.2%$106.23+79.92%
19 qtrssince 2018-Q4
Decreased
0

AbbVie Inc.

32.5M$4.4B1.2%$97.46+23.27%
19 qtrssince 2018-Q4
Decreased
0

Stryker Corporation

14.4M$4.4B1.2%$191.03+54.61%
19 qtrssince 2018-Q4
Decreased
0

CARRIER GLOBAL CORPORATION

83.2M$4.1B1.1%$31.55+51.25%
13 qtrssince 2020-Q2
Increased
54

COMCAST CORP NEW

98.2M$4.1B1.1%$33.71+1.18%
19 qtrssince 2018-Q4
Decreased
0
$373.2B
AUM
414
Positions
Q2 2023
Filing
HI score · 4.0/5
Quarterly 13F Value Change
-11%Q1'22$405.1B-21%Q2'22$321B-5%Q3'22$304.4B+9%Q4'22$330.9B+6%Q1'23$350.4B+7%Q2'23$373.2B
Activity profile
$ moved · Q2'23
New4%Increased47%Decreased44%Exited6%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.1 years
<1Q4%1-4Q12%1-2Y11%2Y+74%

Capital Research Global Investors manages $373.2B across 414 positions as of Q2 2023. Top holdings: MSFT (6.7%), AVGO (4.5%), AMZN (3.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q2 2023 Summary

Active quarter - 22 new positions, 33 exits, 207 increased. Top move: AMZN (INCREASED, conviction 61). Portfolio: $373.2B across 414 positions.

Top holdings by portfolio weight

Total AUM$373B
MSFT6.70%
AVGO4.46%
AMZN3.43%
GE2.72%
ABT2.26%
NFLX2.06%
UNH1.86%
RTX1.75%
META1.67%
GOOGL1.59%
Other1.53%

Portfolio allocation by GICS sector

Sectors11
Technology23.73%
Healthcare15.86%
Consumer Cyclical13.30%
Industrials11.85%
Communication Services8.04%
Financial Services7.48%
Energy6.03%
Consumer Defensive4.45%
Basic Materials3.44%
Utilities3.01%
Other2.81%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L64
Conviction42
Concentration56
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
MOMOALTRIA GROUP INC
Q4 2024 → Q2 2026+46.6M shares+$3.6B
7Q
AEPAEPAMERICAN ELEC PWR CO INC
Q4 2024 → Q2 2026+62,748 shares+$58M
7Q
APHAPHAmphenol Corporation
Q4 2024 → Q2 2026+25.2M shares+$4.9B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used